Angela R. Wu, PhD, is an assistant professor in the Div. of Life Science and the Dept. of Chemical and Biological Engineering at Hong Kong Univ. of Science and Technology in Hong Kong (Clear Water Bay Rd., Clear Water Bay, Kowloon, Hong Kong; Phone: +852 3469-2577; Email: angelawu@ust.hk). She is interested in developing enabling technologies, such as microfluidic devices and single-cell multiomic profiling methods, to bridge gaps between engineering and life sciences as well as to enable discoveries in biology and medicine. Her research group collaborates with clinicians to apply these new technologies in a translational setting. During her postdoctoral work at Stanford Univ., she pioneered some of the single-cell transcriptomics methodologies that are widely used today. She is a founding member of the start-up company Agenovir Corp., based in South San Franscisco, CA. In 2016, she was named one of MIT Technology Review’s Innovators Under 35 in Asia. She received a BS in bioengineering from the Univ. of California, Berkeley, and an MS and PhD in bioengineering from Stanford Univ.